Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Xiao, Zhijie ^a   Wang, Juan ^a   Chen, Weirong ^b   Wang, Peng ^a   Zeng, Houlin ^b   Chen, Weixi ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Medical Center of Women and Children Health Hospital   (China)

Author keywords

Alzheimer's disease; ATP binding cassette transporter A1; Cholesteryl ester transfer protein; LIPC; Lipids; Single nucleotide polymorphisms

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL ESTER TRANSFER PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIVER TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CHINESE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; WECHSLER MEMORY SCALE; WISCONSIN CARD SORTING TEST;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; ATP-BINDING CASSETTE TRANSPORTERS; CHINA; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIPASE; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84869869399     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-163     Document Type: Article

References (130)

1. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Corder EH, Saunders AM, Strittmatter WJ, et al. Science 1993 261 921 923 10.1126/science.8346443 8346443
2. Cholesterol, A beta and Alzheimer's disease. Hartmann T, Trends Neurosci 2001 24 11 Suppl 45 S48 11881745
3. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Martins IJ, Hone E, Foster JK, et al. Molecular Psychiatry 2006 11 721 736 10.1038/sj.mp.4001854 16786033
4. Contribution of vascular risk factors to the progression in Alzheimer disease. Helzner EP, Luchsinger JA, Scarmeas N, et al. Arch Neurol 2009 66 3 343 348 19273753
5. The metabolic syndrome, diabetes, and Alzheimer's disease. García-Lara JM, Aguilar-Navarro S, Gutiérrez-Robledo LM, et al. Rev Invest Clin 2010 62 4 343 349 21218671
6. Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Honig LS, Kukull W, Mayeux R, Neurology 2005 64 3 494 500 10.1212/01.WNL.0000150886.50187.30 15699381
7. Cholesterol-related genes in Alzheimer's disease. Wollmer MA, Biochim Biophys Acta 2010 1801 8 762 773 10.1016/j.bbalip.2010.05.009 20580938
8. Genetic connections between neurological disorders and cholesterol metabolism. Björkhem I, Leoni V, Meaney S, J Lipid Res 2010 51 9 2489 2503 10.1194/jlr.R006338 20466796
9. Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. Martins IJ, Berger T, Sharman MJ, et al. J Neurochem 2009 111 6 1275 1308 10.1111/j.1471-4159.2009.06408.x 20050287
10. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Reitz C, Tang MX, Schupf N, et al. Arch Neurol 2010 67 12 1491 1497 10.1001/archneurol. 2010.297 21149810
11. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Kuo YM, Emmerling MR, Bisgaier CL, Essenburg AD, Lampert HC, Drumm D, Roher AE, Biochem Biophys Res Commun 1998 252 3 711 715 10.1006/bbrc.1998.9652 9837771
12. Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba. Hall K, Murrell J, Ogunniyi A, et al. Neurology 2006 66 2 223 227 10.1212/01.wnl.0000194507.39504.17 16434658
13. Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease. Liu HC, Hu CJ, Chang JG, Sung SM, Lee LS, Yuan RY, Leu SJ, Dement Geriatr Cogn Disord 2006 21 3 155 161 10.1159/000090676 16391478
14. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Anstey KJ, Lipnicki DM, Low LF, Am J Geriatr Psychiatry 2008 16 5 343 354 18448847
15. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Solomon A, Kivipelto M, Wolozin B, et al. Dement Geriatr Cogn Disord 2009 28 1 75 80 10.1159/000231980 19648749
16. Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment. Beydoun MA, Beason-Held LL, Kitner-Triolo MH, Beydoun HA, Ferrucci L, Resnick SM, Zonderman AB, J Epidemiol Community Health 2011 65 11 949 957 10.1136/jech.2009.100826 20841372
17. Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study. Bettermann K, Arnold AM, Williamson J, Rapp S, Sink K, Toole JF, Carlson MC, Yasar S, Dekosky S, Burke GL, J Stroke Cerebrovasc Dis 2012 21 6 436 444 10.1016/j.jstrokecerebrovasdis.2010.11.002 21236699
18. Regulation of beta-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer's disease. Jaya Prasanthi RP, Schommer E, Thomasson S, et al. Mech Ageing Dev 2008 129 11 649 655 10.1016/j.mad.2008.09. 002 18845178
19. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. Thirumangalakudi L, Prakasam A, Zhang R, et al. J Neurochem 2008 106 1 475 485 10.1111/j.1471-4159. 2008.05415.x 18410513
20. Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. Ullrich C, Pirchl M, Humpel C, Mol Cell Neurosci 2010 45 4 408 417 10.1016/j.mcn.2010.08.001 20696249
21. Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle. Ghribi O, J Alzheimers Dis 2008 15 4 673 684 19096164
22. Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. Marwarha G, Dasari B, Prasanthi JR, et al. J Alzheimers Dis 2010 19 3 1007 1019 20157255
23. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Prasanthi JR, Huls A, Thomasson S, et al. Mol Neurodegener 2009 6 4 1
24. Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. Sharma S, Prasanthi RPJ, Schommer E, et al. Neurobiol Dis 2008 32 3 426 432 10.1016/j.nbd.2008.08.002 18775495
25. HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis. Tsompanidi EM, Brinkmeier MS, Fotiadou EH, Giakoumi SM, Kypreos KE, Atherosclerosis 2010 208 1 3 9 10.1016/j.atherosclerosis.2009.05.034 19595353
26. Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. Cavelier C, Lorenzi I, Rohrer L, et al. Biochim Biophys Acta 2006 1761 7 655 666 10.1016/j.bbalip.2006.04.012 16798073
27. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Brooks-Wilson A, Marcil M, Clee SM, et al. Nat Genet 1999 22 336 345 10.1038/11905 10431236
28. ABCA1: at the nexus of cholesterol, HDL and atherosclerosis. Attie AD, Trends Biochem Sci 2007 32 4 172 179 10.1016/j.tibs.2007.02.001 17324574
29. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. Frikke-Schmidt R, Nordestgaard BG, Stene MC, et al. JAMA 2008 299 2524 2532 10.1001/jama.299.21.2524 18523221
30. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis. Ye D, Lammers B, Zhao Y, et al. Curr Drug Targets 2011 12 5 647 660 10.2174/138945011795378522 21039336
31. Hof and Vahram Haroutunian. Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus. Akram A, Schmeidler J, Katsel P, et al. Brain Research 2010 1318 167 177 20079340
32. Lack of ABCA1 considerably decreases brain apoE level and increases amyloid deposition in APP23 mice. Koldamova R, Staufenbiel M, Lefterov I, J Biol Chem 2005 280 52 43224 43235 10.1074/jbc.M504513200 16207713
33. Deletion of abca1 increases Aβdeposition in the PDAPP transgenic mouse model of Alzheimer disease. Wahrle SE, Jiang H, Parsadanian M, et al. J Biol Chem 2005 280 52 43236 43242 10.1074/jbc.M508780200 16207708
34. ABCA1, but not ABCG1, modulates brain amyloid deposition in the PDAPP mouse model of Alzheimer's disease. Wellington CL, Alzheimer's and Dementia 2008 4 151 23209820
35. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. Wahrle SE, Jiang H, Parsadanian M, et al. J Clin Investig 2008 118 2 671 682 18202749
36. The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease. Hirsch-Reinshagen V, Maia LF, Burgess BL, et al. J Biol Chem 2005 280 43243 43256 10.1074/jbc.M508781200 16207707
37. Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid-beta peptide levels in vivo. Hirsch-Reinshagen V, Chan JY, Wilkinson A, et al. J Lipid Res 2007 48 914 923 10.1194/jlr.M600543-JLR200 17235115
38. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Wollmer MA, Streffer JR, Lutjohann D, et al. Neurobiol Aging 2003 24 3 421 426 10.1016/S0197-4580(02)00094-5 12600718
39. Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Zambon A, Deeb SS, Pauletto P, Crepaldi G, Brunzell JD, Curr Opin Lipidol 2003 14 2 179 189 10.1097/00041433-200304000-00010 12642787
40. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Santamarina-Fojo S, Haudenschild C, Amar M, Curr Opin Lipidol 1998 9 3 211 219 10.1097/00041433-199806000-00005 9645503
41. Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors. Barter PJ, Atheroscler Suppl 2002 3 4 39 47 10.1016/S1567-5688(02) 00041-7 12573362
42. Genetic variations of the hepatic lipase gene in Korean patients with coronary artery disease. Hong SH, Song J, Kim JQ, Clin Biochem 2000 33 4 291 296 10.1016/S0009-9120(00)00077-1 10936588
43. Cholesteryl ester transfer protein and hepatic lipase gene polymorphisms: Effects on hepatic mRNA levels, plasma lipids and carotid atherosclerosis. Soyal SM, Sandhofer A, Hahne P, et al. Atherosclerosis 2011 216 2 374 380 10.1016/j.atherosclerosis.2011.01.052 21371711
44. Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study. Kashani Farid MA, Azizi F, Hedayati M, et al. Lipids Health Dis 2010 9 96 10.1186/1476-511X-9-96 20822508
45. Quantitative assessment of the effect of hepatic lipase gene polymorphism on the risk of coronary heart disease. Wang H, Jiang M, Qiu J, Arch Med Res 2010 41 5 383 390 10.1016/j.arcmed.2010.08.004 20851298
46. Structure of the human hepatic triglyceride lipase gene. Cai SJ, Wong DM, Chen SH, Chan L, Biochemistry 1989 28 23 8966 8971 10.1021/bi00449a002 2605236
47. Hepatic lipase: structure/function relationship, synthesis, and regulation. Perret B, Mabile L, Martinez L, et al. J Lipid Res 2002 43 1163 1169 12177160
48. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene: the LOCAT Study Investigators. Tahvanainen E, Syvänne M, Frick M, Murtomäki-Repo S, Antikainen M, Kesäniemi Y, Kauma H, Pasternak A, Taskinen M, Ehnholm C, J Clin Invest 1998 101 956 960 10.1172/JCI1144 9486964
49. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Zambon A, Deeb SS, Hokanson JE, Brown BG, Brunzell JD, Arterioscler Thromb Vasc Biol 1998 18 11 1723 1729 10.1161/01.ATV.18.11.1723 9812910
50. Hepatic lipase gene -514C/T polymorphism in the Guangxi Hei Yi Zhuang and Han populations. Wu J, Yin R, Lin W, et al. Lipids 2008 43 8 733 740 10.1007/s11745-008-3204-3 18592285
51. Association between -250 G/A polymorphism of the hepatic lipase gene promoter and coronary artery disease and HDL-C levels in a Southern Brazilian population. de Andrade FM, Silveira FR, Arsand M, et al. lin Genet 2004 65 5 390 395 10.1111/j.0009-9163.2004.00243.x
52. Association of the hepatic lipase gene -250 G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease. Wei M, Lu YS, Li PP, Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2009 26 2 219 222 19350521
53. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Drayna D, Lawn R, Nucleic Acids Res 1987 15 11 4698 10.1093/nar/15.11. 4698 2884631
54. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Katzov H, Chalmers K, Palmgren J, et al. Hum Mutat 2004 23 4 358 367 10.1002/humu.20012 15024730
55. Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. Li Y, Tacey K, Doil L, et al. Neurosci Lett 2004 366 3 268 271 10.1016/j.neulet.2004.05.047 15288432
56. Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. Sundar PD, Feingold E, Minster RL, et al. Neurobiol Aging 2007 28 6 856 862 10.1016/j.neurobiolaging.2006.04.005 16725228
57. Correlation of cholesterol 24-hydroxylase and ATP-binding cassette transporter A1 polymorphisms with Alzheimer's disease. Wang F, Jia JP, Zhonghua Yi Xue Za Zhi 2007 87 9 614 618 17550732
58. Association of genetic variants of ABCA1 with Alzheimer's disease risk. Rodríguez-Rodríguez E, Mateo I, Llorca J, et al. Am J Med Genet B Neuropsychiatr Genet 2007 144B 7 964 968 10.1002/ajmg.b.30552 17510946
59. Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE epsilon4 in Chinese. Chen DW, Yang JF, Tang Z, et al. Brain Res 2008 1187 52 57 18036514
60. No association of lipase C polymorphisms with Alzheimer's disease. Laws SM, Eckart K, Friedrich P, et al. Neurobiol Aging 2010 31 12 2192 2193 10.1016/j.neurobiolaging.2008.12.004 19155102
61. Lack of association of hepatic lipase polymorphisms with late-onset Alzheimer's disease. Zhu H, Taylor JW, Bennett DA, et al. Neurobiol Aging 2008 29 5 793 794 10.1016/j.neurobiolaging.2006.11.015 17175070
62. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Folstein MF, Folstein SE, McHugh PR, J Psychiatr Res 1975 12 3 189 198 10.1016/0022-3956(75)90026-6 1202204
63. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, Neurology 1984 34 7 939 944 10.1212/WNL.34.7.939 6610841
64. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, JAMA 2001 285 19 2486 2497 10.1001/jama.285.19.2486 11368702
65. Common genetic variation in abca1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Clee SM, Zw inderman AH, Engert JC, et al. Circulation 2001 103 1198 1205 10.1161/01.CIR.103.9.1198 11238261
66. Association of LIPC -250 G > A polymorphism and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han Populations. Li M, Yin R, Li Y, et al. Lipids in Health and Disease 2010 9 28 10.1186/1476-511X-9-28 20222961
67. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population. Corella D, Sáiz C, Guillén M, Portolés O, Mulet F, González JI, Ordovás JM, Atherosclerosis 2000 152 2 367 376 10.1016/S0021-9150(99) 00477-3 10998464
68. Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. Merched A, Xia Y, Visvikis S, Serot JM, Siest G, Neurobiol Aging 2000 21 1 27 30 10.1016/S0197-4580(99)00103-7 10794845
69. Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease. Pani A, Mandas A, Diaz G, et al. BMC Med 2009 7 66 10.1186/1741-7015-7- 66 19883495
70. Relation of plasma lipids to Alzheimer disease and vascular dementia. Reitz C, Tang MX, Luchsinger J, et al. Arch Neurol 2004 61 5 705 714 10.1001/archneur.61.5.705 15148148
71. High total cholesterol levels in late life associated with a reduced risk of dementia. Mielke MM, Zandi PP, Sjögren M, et al. Neurology 2005 64 10 1689 1695 10.1212/01.WNL.0000161870.78572.A5 15911792
72. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. Hendrie HC, Ogunniyi A, Hall KS, Baiyewu O, Unverzagt FW, Gureje O, Gao S, Evans RM, Ogunseyinde AO, Adeyinka AO, Musick B, Hui SL, JAMA 2001 285 6 739 747 10.1001/jama.285.6.739 11176911
73. Plasma Abeta42 correlates positively with increased body fat in healthy individuals. Balakrishnan K, Verdile G, Mehta PD, Beilby J, Nolan D, Galvão DA, Newton R, Gandy SE, Martins RN, J Alzheimers Dis 2005 8 3 269 282 16340084
74. Homocysteine, another risk factor for Alzheimer disease, impairs apolipoprotein E3 function. Minagawa H, Watanabe A, Akatsu H, et al. J Biol Chem 2010 285 49 38382 38388 10.1074/jbc.M110.146258 20889503
75. Age-varying association between statin use and incident Alzheimer's disease. Li G, Shofer JB, Rhew IC, Kukull WA, Peskind ER, McCormick W, Bowen JD, Schellenberg GD, Crane PK, Breitner JC, Larson EB, J Am Geriatr Soc 2010 58 7 1311 1317 10.1111/j.1532-5415.2010.02906.x 20533968
76. Plasma lipid levels in Alzheimer's disease patients treated by Donepezil hydrochloride: a cross-sectional study. Adunsky A, Chesnin V, Ravona R, et al. Arch Gerontol Geriatr 2004 38 1 61 68 10.1016/j.archger.2003.08.002 14599705
77. Cholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofibrillary tangles. Lesser GT, Beeri MS, Schmeidler J, et al. Curr Alzheimer Res 2011 8 3 303 312 10.2174/156720511795563755 21244352
78. Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease. Kölsch H, Lütjohann D, Jessen F, et al. Int J Mol Med 2006 17 5 791 794 16596262
79. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A, J Clin Invest 2004 114 1343 1353 15520867
80. ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice. Donkin JJ, Stukas S, Hirsch-Reinshagen V, et al. J Biol Chem 2010 285 44 34144 34154 10.1074/jbc.M110.108100 20739291
81. Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics. Lee JH, Mayeux R, Mayo D, et al. Mol Psychiatry 2004 9 11 1042 1051 10.1038/sj.mp.4001538 15241431
82. Associations of the ATP-binding cassette transporter A1 R219K polymorphism with HDL-C level and coronary artery disease risk: a meta-analysis. Ma XY, Liu JP, Song ZY, Atherosclerosis 2011 215 2 428 434 10.1016/j. atherosclerosis.2011.01.008 21310416
83. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Yvan-Charvet L, Wang N, Tall AR, Arterioscler Thromb Vasc Biol 2010 30 2 139 143 10.1161/ATVBAHA.108.179283 19797709
84. Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL. Soro-Paavonen A, Naukkarinen J, Lee-Rueckert M, et al. J Lipid Res 2007 48 6 1409 1416 10.1194/jlr.P600012-JLR200 17372331
85. A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia. Cenarro A, Artieda M, Castillo S, et al. J Med Genet 2003 40 3 163 168 10.1136/jmg.40.3.163 12624133
86. Genetic variation of the ATP-binding cassette transporter A1 and susceptibility to coronary heart disease. Jiang Z, Zhou R, Xu C, et al. Mol Genet Metab 2011 103 1 81 88 10.1016/j.ymgme.2011.01.005 21300560
87. Genotypic variation in ATP-binding cassette transporter-1 (ABCA1) as contributors to the high and low high-density lipoprotein-cholesterol (HDL-C) phenotype. Mantaring M, Rhyne J, Ho Hong S, et al. Transl Res 2007 149 4 205 210 10.1016/j.trsl.2006.11.007 17383594
88. Effects of ABCA1 SNPs, including the C-105 T novel variant, on serum lipids of Brazilian individuals. Genvigir FD, Soares SA, Hirata MH, et al. Clin Chim Acta 2008 389 1-2 79 86 18164264
89. A novel haplotype in ABCA1 gene effects plasma HDL-C concentration. Saleheen D, Khanum S, Haider SR, et al. Int J Cardiol 2007 115 1 7 13 10.1016/j.ijcard.2005.12.020 16806540
90. Genetic variation in ABCA1 predicts ischemic heart disease in the general population. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, et al. Arterioscler Thromb Vasc Biol 2008 28 1 180 186 17951323
91. ATP-binding cassette transporter A1 gene polymorphisms and serum lipid levels in young Greek nurses. Kolovou V, Kolovou G, Marvaki A, et al. Lipids Health Dis 2011 10 56 10.1186/1476-511X-10-56 21489276
92. Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks. Hodoǧlugil U, Williamson DW, Huang Y, et al. Atherosclerosis 2005 183 2 199 212 10.1016/j.atherosclerosis. 2005.03.004 15935359
93. Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis. Tsai MY, Li N, Sharrett AR, et al. Clin Chem 2009 55 3 481 488 10.1373/clinchem.2008.107995 19131637
94. Relationship between ATP-binding cassette transporter 1 R219K genetic variation and blood lipids. Zhao SP, Xiao ZJ, Li QZ, et al. Zhonghua Yi Xue Za Zhi 2004 84 17 1421 1425 15500734
95. Association of selected ABC gene family single nucleotide polymorphisms with postprandial lipoproteins: results from the population-based Hortega study. Abellán R, Mansego ML, Martínez-Hervás S, et al. Atherosclerosis 2010 211 1 203 209 10.1016/j.atherosclerosis.2010.01.030 20170916
96. Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-beta 1-42 and plasma apolipoprotein levels. Katzov H, Bennet AM, Höglund K, et al. J Hum Genet 2006 51 3 171 179 10.1007/s10038-005-0341-x 16372134
97. ABCA1 single nucleotide polymorphisms on high-density lipoprotein-cholesterol and overweight: the D.E.S.I.R. Study. Porchay I, Péan F, Bellili N, et al. Obesity (Silver Spring) 2006 14 11 1874 1879 10.1038/oby.2006.217
98. Differential effect of ATP binding cassette transporter A1 R219K and cholesteryl ester transfer protein TaqIB genotypes on HDL-C levels in overweight/obese and non-obese Chinese subjects. Huang Y, Wu Y, Liu R, et al. Acta Cardiol 2011 66 2 231 237 21591583
99. The effect of ABCA1 gene polymorphisms on ischaemic stroke risk and relationship with lipid profile. Pasdar A, Yadegarfar G, Cumming A, et al. BMC Med Genet 2007 8 30 17553166
100. Effect of R219K polymorphism of the ABCA1 gene on the lipid-lowering effect of pravastatin in Chinese patients with coronary heart disease. Li J, Wang LF, Li ZQ, et al. Clin Exp Pharmacol Physiol 2009 36 5-6 567 570 19673941
101. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. Thompson A, Di Angelantonio E, Sarwar N, et al. JAMA 2008 299 23 2777 2788 10.1001/jama.299.23.2777 18560005
102. Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome. Stancáková A, Baldaufová L, Javorský M, et al. Physiol Res 2006 55 5 483 490 16343038
103. The -250 G- > A polymorphism in the human hepatic lipase gene promoter affects blood lipids in Chinese. Zhao S, Xie X, Nie S, Clin Chim Acta 2006 365 1-2 149 152 16153627
104. The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese. Ko YL, Hsu LA, Hsu KH, et al. Atherosclerosis 2004 172 1 135 142 10.1016/j.atherosclerosis.2003.09.013 14709367
105. Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake. Dichek HL, Brecht W, Fan J, et al. J Biol Chem 1998 273 4 1896 1903 10.1074/jbc.273.4.1896 9442022
106. Interactions between hepatic lipase and apolipoprotein E gene polymorphisms affect serum lipid profiles of healthy Canadian adults. Wood KC, Fullerton MD, El-Sohemy A, et al. Appl Physiol Nutr Metab 2008 33 4 761 768 10.1139/H08-054 18641720
107. Hepatic lipase: a pro- or anti-atherogenic protein? Jansen H, Verhoeven AJ, Sijbrands EJ, J Lipid Res 2002 43 9 1352 1362 10.1194/jlr.R200008-JLR200 12235167
108. Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins. Zambon A, Bertocco S, Vitturi N, Polentarutti V, Vianello D, Crepaldi G, Biochem Soc Trans 2003 31 Pt 5 1070 1074 14505482
109. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Guerra R, Wang J, Grundy SM, Cohen JC, Proc Natl Acad Sci U S A 1997 94 9 4532 4537 10.1073/pnas.94.9.4532 9114024
110. Cholesteryl ester transfer protein and its plasma regulator: lipid transfer inhibitor protein. Morton RE, Curr Opin Lipidol 1999 10 4 321 327 10.1097/00041433-199908000-00006 10482135
111. Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects. Fiegenbaum M, da Silveira FR, Van der Sand CR, et al. Clin Chim Acta 2005 362 1-2 182 188 16038892
112. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis. Arca M, Montali A, Ombres D, Battiloro E, Campagna F, Ricci G, Verna R, Clin Genet 2001 60 5 374 380 11903340
113. Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: the Atherosclerosis Risk in Communities (ARIC) Study. Chamberlain AM, Folsom AR, Schreiner PJ, et al. Atherosclerosis 2008 200 2 322 328 10.1016/j.atherosclerosis.2007.12.045 18275964
114. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Saxena R, Voight BF, Lyssenko V, et al. Science 2007 316 1331 1336 17463246
115. Epistatic effect of cholesteryl ester transfer protein and hepatic lipase on serum high-density lipoprotein cholesterol levels. Isaacs A, Aulchenko YS, Hofman A, et al. J Clin Endocrinol Metab 2007 92 2680 2687 10.1210/jc.2007-0269 17440012
116. Polymorphisms associated with cholesterol and risk of cardiovascular events. Kathiresan S, Melander O, Anevski D, et al. N Engl J Med 2008 358 12 1240 1249 10.1056/NEJMoa0706728 18354102
117. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Willer CJ, Sanna S, Jackson AU, et al. Nat Genet 2008 40 2 161 169 10.1038/ng.76 18193043
118. Effects of the amount and intensity of exercise on plasma lipoproteins. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD, Kulkarni KR, Slentz CA, N Engl J Med 2002 347 19 1483 1492 10.1056/NEJMoa020194 12421890
119. CETP (cholesteryl ester transfer protein) promoter -1337 C > T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia. Takata M, Inazu A, Katsuda S, et al. Clin Sci (Lond) 2006 11 5 325 331
120. Astroglial localization of cholesteryl ester transfer protein in normal and Alzheimer's disease brain tissues. Yamada T, Kawata M, Arai H, Fukasawa M, Inoue K, Sato T, Acta Neuropathol 1995 90 6 633 636 10.1007/BF00318577 8615085
121. The cholesteryl ester transfer protein (CETP) gene and the risk of Alzheimer's disease. Arias-Vásquez A, Isaacs A, Aulchenko YS, Hofman A, Oostra BA, Breteler M, van Duijn CM, Neurogenetics 2007 8 3 189 193 10.1007/s10048-007-0089-x 17503098
122. Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia. Sanders AE, Wang C, Katz M, et al. JAMA 2010 303 2 150 158 10.1001/jama.2009. 1988 20068209
123. Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimers disease. Zhu H, Gopalraj RK, Kelly JF, Bennett DA, Estus S, Neurosci Lett 2005 381 1-2 36 41 15882786
124. CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk. Qureischie H, Heun R, Lütjohann D, et al. Brain Res 2008 1232 1 6 18680734
125. An association study of the cholesteryl ester transfer protein TaqI B polymorphism with late onset Alzheimer's disease. Fidani L, Goulas A, Crook R, Petersen RC, Tangalos E, Kotsis A, Hardy J, Neurosci Lett 2004 357 2 152 154 10.1016/j.neulet.2003.11.071 15036597
126. Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. Letenneur L, Gilleron V, Commenges D, Helmer C, Orgogozo JM, Dartigues JF, J Neurol Neurosurg Psychiatry 1999 66 2 177 183 10.1136/jnnp.66.2.177 10071096
127. Influence of education and occupation on the incidence of Alzheimer's disease. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R, JAMA 1994 271 13 1004 1010 10.1001/jama.1994.03510370056032 8139057
128. Education, the brain and dementia: neuroprotection or compensation? EClipSE Collaborative M, Brayne C, Ince PG, et al. Brain 2010 133 Pt 8 2210 2216 20826429
129. Higher education delays and shortens cognitive impairment: a multistate life table analysis of the US Health and Retirement Study. Reuser M, Willekens FJ, Bonneux L, Eur J Epidemiol 2011 26 5 395 403 10.1007/s10654-011-9553-x 21337033
130. The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Cobb JL, Wolf PA, Au R, et al. Neurology 1995 45 9 1707 1712 10.1212/WNL.45.9.1707 7675231